We're the national organization providing support, resources, volunteer opportunities and hope for people fighting pancreatic ...

The Carol Kulok Award for Compassion is given to a PanCAN Patient Services team member who has gone above and beyond services ...

Join PanCAN on World Pancreatic Cancer Day, November 20, at 11 a.m. PT / 2 p.m. ET, for a free webinar featuring top ...

Maximize your IMPACT in the fight against pancreatic cancer! Did you know that thousands of companies match donations made by [...] READ MORE ...

PanCAN welcomes Jon Mahrt, Chief Executive Officer of Optum Rx and Chief Growth Officer of Optum to the Board of Directors. In this Q&A, Jon shares his personal connection to the cause, his passion ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Restorative White Bean Soup - Pancreatic Cancer Action NetworkWholesome, Plant-Based Comfort in Every Spoonful Makes: 6 Servings By: Alison Tierney, MS, RD, CSO Website: www.wholesomellc.com ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and New Treatments for Patients LOS ANGELES, Calif. – (January 16, 2025) – After ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...

The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 gene fusion found in roughly 3% of patients with pancreatic ...